Literature DB >> 29625260

Protective effects of Polygonum multiflorum on ischemic stroke rat model analysed by 1H NMR metabolic profiling.

Ming-Hui Li1, Ling-Yu Ruan1, Cheng Chen1, Yue-Xiao Xing1, Wei Hong1, Rong-Hui Du2, Jun-Song Wang3.   

Abstract

Stroke is the third most common cause of death in most industrialized countries. Polygonum multiflorum (He-Shou-Wu, HSW) is one of the traditional Chinese medicines with multiple pharmacological activities which is widely used in Chinese recipe. This study aims to explore the protective effect of HSW on ischemic stroke rat model and to elucidate the underlying mechanisms. The mortality rate, neurological deficit, cerebral infarct size, histopathology, immunohistochemistry, biochemical parameters, quantitative real-time polymerase chain reaction and western blotting were used to access the treatment effects of HSW on ischemic stroke. Proton nuclear magnetic resonance (1H NMR) based metabolomics analysis disclosed that HSW could relieve stroke rats suffering from the ischemia/reperfusion injury by ameliorating the disturbed energy and amino acids metabolisms, alleviating the oxidative stress from reactive oxygen species and reducing the inflammation. HSW treatment increased levels of cellular antioxidants that scavenged reactive oxygen species during ischemia-reperfusion via the nuclear erythroid 2-related factor 2 signaling pathway, and exert anti-inflammatory effect by decreasing the levels of inflammatory factors such as cyclooxygenase-2, interleukin-1β, interleukin-6 and tumor necrosis factor-α. The integrated metabolomics approach showed its potential in understanding mechanisms of HSW in relieving ischemic stroke. Further study to develop HSW as an effective therapeutic agent to treat ischemic stroke is warranted.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cerebral ischemia reperfusion; Correlation network; Metabolic pathway analysis; Nuclear magnetic resonance; Polygonum multiflorum

Mesh:

Substances:

Year:  2018        PMID: 29625260     DOI: 10.1016/j.jpba.2018.03.049

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  4 in total

1.  Preparation, Characterization and in vivo Study of Borneol-Baicalin-Liposomes for Treatment of Cerebral Ischemia-Reperfusion Injury.

Authors:  Yulu Zhang; Songyu Liu; Jinyan Wan; Qiyue Yang; Yan Xiang; Li Ni; Yu Long; Mingquan Cui; Zhimin Ci; Donglei Tang; Nan Li
Journal:  Int J Nanomedicine       Date:  2020-08-12

Review 2.  Metabolome Changes in Cerebral Ischemia.

Authors:  Tae Hwan Shin; Da Yeon Lee; Shaherin Basith; Balachandran Manavalan; Man Jeong Paik; Igor Rybinnik; M Maral Mouradian; Jung Hwan Ahn; Gwang Lee
Journal:  Cells       Date:  2020-07-07       Impact factor: 6.600

3.  The cardioprotective effects of the new crystal form of puerarin in isoproterenol-induced myocardial ischemia rats based on metabolomics.

Authors:  Yuzhi Zhou; Mengru Li; Jia Song; Yongqiang Shi; Xuemei Qin; Zhaolin Gao; Yang Lv; Guanhua Du
Journal:  Sci Rep       Date:  2020-10-20       Impact factor: 4.379

Review 4.  Recent Advances in Chinese Herbal Medicine for Cerebral Ischemic Reperfusion Injury.

Authors:  Ping Huang; Haitong Wan; Chongyu Shao; Chang Li; Ling Zhang; Yu He
Journal:  Front Pharmacol       Date:  2022-01-17       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.